arrow
返回
A

Anders Malmberg

ferring pharmaceuticals

33H指数
119论文数
1.2W被引数
收录论文 8
发表时间
Factors Predicting the Off-treatment Duration in Patients with Prostate Cancer Receiving Degarelix as Intermittent Androgen Deprivation Therapy
err2017-10-01
err3
errOAAI
errAbrahamsson, Per-Anders; Boccon-Gibod, Laurent; Morote, Juan; de Jong, Igle Jan; Malmberg, Anders; Neijber, Anders; Albers, Peter
err分享
err收藏
Low-dose desmopressin combined with serum sodium monitoring can prevent clinically significant hyponatraemia in patients treated for nocturia
err2016-12-10
err29
PREAI
errJuul, Kristian Vinter; Malmberg, Anders; van der Meulen, Egbert; Walle, Johan Vande; Norgaard, Jens Peter
err分享
err收藏
CARDIOVASCULAR EVENT RISK AS A FUNCTION OF BASELINE RISK FACTORS IN PROSTATE CANCER PATIENTS TREATED WITH DEGARELIX OR LUTEINISING HORMONE-RELEASING HORMONE AGONISTS
err2015-04-01
err0
PREAI
errde Jong, Igle; Tivesten, Asa; de la Taille, Alexandre; Montorsi, Francesco; Malmberg, Anders; Persson, Bo-Eric
err分享
err收藏
Disease Control Outcomes from Analysis of Pooled Individual Patient Data from Five Comparative Randomised Clinical Trials of Degarelix Versus Luteinising Hormone-releasing Hormone Agonists
err2014-12-01
err81
PREAI
errKlotz, Laurence; Miller, Kurt; Crawford, E. David; Shore, Neal; Tombal, Bertrand; Karup, Cathrina; Malmberg, Anders; Persson, Bo-Eric
err分享
err收藏
Degarelix as an Intermittent Androgen Deprivation Therapy for One or More Treatment Cycles in Patients with Prostate Cancer
err2014-10-01
err21
PREAI
errBoccon-Gibod, Laurent; Albers, Peter; Morote, Juan; van Poppel, Hendrik; de la Rosette, Jean; Villers, Arnauld; Malmberg, Anders; Neijber, Anders; Montorsi, Francesco
err分享
err收藏